ASX:AYAHealth Care Equipment & ServicesHealth Care Technology
ARTRYA ORD
$3.530
$0.210 (5.62%)
Day Range
$3.430 - $3.820
52 Week Range
$0.560 - $5.240
Volume
1.23M
Avg Volume (10D)
645.85K
Market Cap
$558.04M
Price Chart
Market Statistics
Open$3.800
Previous Close$3.740
Day High$3.820
Day Low$3.430
52 Week High$5.240
52 Week Low$0.560
Valuation
Market Cap558.04M
Shares Outstanding158.08M
Price to Book18.80
Trading Activity
Volume1.23M
Value Traded4.37M
Bid$3.460 × 5,000
Ask$3.530 × 3,080
Performance
1 Day-5.61%
5 Day-14.94%
13 Week3.52%
52 Week292.22%
YTD-25.05%
Technical Indicators
RSI (14)35.62
50-Day SMA$3.911
200-Day SMA$2.192
Latest News
Biotechnology
Artrya Secures Second US Commercial Order for Salix SaaS Platform to Manage Coronary Artery Disease
Artrya (ASX: AYA) has signed a commercial agreement with US-based Northeast Georgia Health System for the use of its Salix AI cloud platform for point-of-care assessment and management of coronary artery disease.
1 min read
Biotechnology
Artrya Wins FDA Clearance to Advance Rollout of Salix Coronary Plaque Module
Artrya (ASX: AYA) has received clearance from the US Food and Drug Administration for its Salix Coronary Plaque module. The regulatory milestone enables the company to charge per-scan fees in its largest market, significantly enhancing revenue potential. The approval follows Artrya’s recent US launch and builds on momentum established with its Salix Coronary Anatomy platform. […]
3 min read
